With every passing day, new discoveries are made that lend support to the increasing and important role biomarker analysis and tumor profiling play in personalized cancer care. Caris Life Sciences® is actively participating in research to advance the understanding of molecular science, further enabling the delivery of precision medicine.

Comprehensive genomic profiling of mucinous ovarian carcinoma with comparisons to mucinous colorectal carcinoma

Molecular portraits of clear cell ovarian and endometrial carcinoma with comparison to clear cell renal cell carcinoma

Comprehensive molecular profiles of low‐grade serous ovarian cancer

Comprehensive molecular profiling of signet-ring-cell carcinoma (SRCC) from the stomach and colon.

Characteristics of Colorectal Cancer (CRC) Patients with BRCA1 and BRCA2 Mutations

Association of DNA damage response and repair gene (DDR) mutations and microsatellite instability (MSI), PD-L1 expression, tumor mutational burden (TMB) in gastroesophageal cancers

Gene-specific features (MLH1, MSH2, MSH6, PMS2) of mismatch repair (MMR) protein expression and somatic mutations, microsatellite instability (MSI), and tumor mutational burden (TMB) in MSI-H and MMR-mutated tumor genomic profiles

Molecular Characterization of Early vs. Late Onset Gastroesophagel Cancer

Predictive Biomarker Profiling of > 6000 Breast Cancer Patients Shows Heterogeneity in TNBC, With Treatment Implications

Racial differences in the molecular landscape of breast